Structure of LIMP-2 provides functional insights with implications for SR-BI and CD36

Nature

Volumn 504, Issue 7478, 2013, Pages 172-176

  Neculai, Dante ^a   Schwake, Michael ^b,c   Ravichandran, Mani ^d   Zunke, Friederike ^b   Collins, Richard F ^a   Peters, Judith ^b   Neculai, Mirela ^d   Plumb, Jonathan ^a   Loppnau, Peter ^d   Pizarro, Juan Carlos ^d,e   Seitova, Alma ^d   Trimble, William S ^a,f   Saftig, Paul ^b   Grinstein, Sergio ^a,f,g   Dhe Paganon, Sirano ^d,h  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF KIEL   (Germany)

^c BIELEFELD UNIVERSITY   (Germany)

^d UNIVERSITY OF TORONTO   (Canada)

^e TULANE UNIVERSITY   (United States)

^f UNIVERSITY OF TORONTO   (Canada)

^g ST MICHAEL'S HOSPITAL   (Canada)

^h DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSYLCERAMIDASE; LIMP 2 PROTEIN; SCAVENGER RECEPTOR BI; UNCLASSIFIED DRUG;

IMMUNITY; LIGAND; LIPID; METABOLISM; MOLECULAR ANALYSIS; MUTAGENICITY; PLASMA; PROTEIN;

ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; CRYSTAL STRUCTURE; ENTEROVIRUS 71; HUMAN; HUMAN CELL; INNATE IMMUNITY; INSECT CELL; LIPID METABOLISM; MUTAGENESIS; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN STRUCTURE;

ANIMALS; ANTIGENS, CD36; CHO CELLS; CRICETULUS; HELA CELLS; HUMANS; LYSOSOME-ASSOCIATED MEMBRANE GLYCOPROTEINS; MODELS, MOLECULAR; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY;

HEPATITIS C VIRUS; HUMAN ENTEROVIRUS 71;

EID: 84889609917     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature12684     Document Type: Article

References (21)

1. Canton, J., Neculai, D. & Grinstein, S. Scavenger receptors in homeostasis and immunity. Nature Rev. Immunol. 13, 621-634 (2013).
2. Rodrigueza, W. V. et al. Mechanism of scavenger receptor class B type I-mediated selective uptake of cholesteryl esters fromhigh density lipoprotein to adrenal cells. J. Biol. Chem. 274, 20344-20350 (1999).
3. Yu, M. et al. Exoplasmic cysteine Cys384 of theHDL receptor SR-BI is critical for its sensitivity to a small-molecule inhibitor and normal lipid transport activity. Proc. Natl Acad. Sci. USA 108, 12243-12248 (2011).
4. Rasmussen, J. T., Berglund, L., Rasmussen, M. S. & Petersen, T. E. Assignment of disulfide bridges in bovine CD36. Eur. J. Biochem. 257, 488-494 (1998).
5. Reczek, D. et al. LIMP-2 is a receptor for lysosomal mannose-6- phosphateindependent targeting of b-glucocerebrosidase. Cell 131, 770-783 (2007).
6. Blanz, J. et al. Disease-causingmutations within the lysosomal integralmembrane protein type 2 (LIMP-2) reveal the nature of binding to its ligand b-glucocerebrosidase. Hum. Mol. Genet. 19, 563-572 (2010).
7. Zachos, C., Blanz, J., Saftig, P. & Schwake, M. A critical histidine residue within LIMP-2 mediates pH sensitive binding to its ligand b-glucocerebrosidase. Traffic 13, 1113-1123 (2012).
8. Ryeom, S. W., Silverstein, R. L., Scotto, A. & Sparrow, J. R. Binding of anionic phospholipids to retinal pigment epithelium may be mediated by the scavenger receptor CD36. J. Biol. Chem. 271, 20536-20539 (1996).
9. Jimenez-Dalmaroni, M. J. et al. Soluble CD36 ectodomain binds negatively charged diacylglycerol ligands and acts as a co-receptor for TLR2. PLoS ONE 4, e7411 (2009).
10. Puente Navazo, M. D., Daviet, L., Ninio, E. & McGregor, J. L. Identification on human CD36 of a domain (155-183) implicated in binding oxidized low-density lipoproteins (Ox-LDL). Arterioscler. Thromb. Vasc. Biol. 16, 1033-1039 (1996).
11. Stylianou, I. M. et al. Novel ENU-induced point mutation in scavenger receptor class B, member 1, results in liver specific loss of SCARB1 protein. PLoS ONE 4, e6521 (2009).
12. Chadwick, A. C. & Sahoo, D. Functional characterization of newly-discovered mutations in human SR-BI. PLoS ONE 7, e45660 (2012).
13. Kar, N. S., Ashraf, M. Z., Valiyaveettil, M. & Podrez, E. A. Mapping and characterization of the binding site for specific oxidized phospholipids and oxidized low density lipoprotein of scavenger receptor CD36. J. Biol. Chem. 283, 8765-8771 (2008).
14. Rigotti, A., Miettinen, H. E. & Krieger, M. The role of the high-density lipoprotein receptor SR-BI in the lipid metabolismof endocrine and other tissues. Endocr. Rev. 24, 357-387 (2003).
15. Gu, X. et al. The efficient cellular uptake of high density lipoprotein lipids via scavenger receptor class B type I requires not only receptor-mediated surface binding but also receptor-specific lipid transfer mediated by its extracellular domain. J. Biol. Chem. 273, 26338-26348 (1998).
16. Liu, B.&Krieger, M. Highly purified scavenger receptor class B, type I reconstituted into phosphatidylcholine/cholesterol liposomes mediates high affinity high density lipoprotein binding and selective lipid uptake. J. Biol. Chem. 277, 34125-34135 (2002).
17. Gu, X., Kozarsky, K. & Krieger, M. Scavenger receptor class B, type I-mediated [3H]cholesterol efflux to high and low density lipoproteins is dependent on lipoprotein binding to the receptor. J. Biol. Chem. 275, 29993-30001 (2000).
18. Ji, Y. et al. Scavenger receptor BI promotes high density lipoprotein-mediated cellular cholesterol efflux. J. Biol. Chem. 272, 20982-20985 (1997).
19. Nieland, T. J., Penman, M., Dori, L., Krieger, M. & Kirchhausen, T. Discovery of chemical inhibitors of the selective transfer of lipidsmediated by theHDL receptor SR-BI. Proc. Natl Acad. Sci. USA 99, 15422-15427 (2002).
20. Nieland, T. J. et al. Identificationof themolecular target ofsmallmolecule inhibitors of HDL receptor SR-BI activity. Biochemistry 47, 460-472 (2008).
21. Yu, M., Lau, T. Y., Carr, S. A. & Krieger, M. Contributions of a disulfide bond and a reduced cysteine side chain to the intrinsic activity of the high-density lipoprotein receptor SR-BI. Biochemistry 51, 10044-10055 (2012).